Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carmen Pupareli"'
Autor:
Gonzalo Ruiz, Diego Enrico, Yamil D. Mahmoud, Alan Ruiz, María Florencia Cantarella, Laura Leguina, Mariana Barberis, Asunción Beña, Esteban Brest, Solange Starapoli, Andrea Mendoza Bertelli, Florencia Tsou, Carmen Pupareli, María Pía Coppola, Alejandra Scocimarro, Susana Sena, Patricio Levit, Aldo Perfetti, Enrique Aman, María Romina Girotti, Oscar Arrieta, Claudio Martín, Rubén Salanova
Publikováno v:
Thoracic Cancer, Vol 15, Iss 11, Pp 895-905 (2024)
Abstract Background Programmed death ligand‐1 (PD‐L1) expression is a well‐known predictive biomarker of response to immune checkpoint blockade in non‐small cell lung cancer (NSCLC). However, there is limited evidence of the relationship betw
Externí odkaz:
https://doaj.org/article/35b2c471fd2f4394a99e4501ff344c9d
Autor:
Diego Enrico, MD, Florencia Tsou, MD, Greta Catani, MD, Carmen Pupareli, MD, María Romina Girotti, PhD, David Esteban Ulloa Alvarez, MD, Federico Waisberg, MD, Andrés Rodríguez, MD, Roxana Reyes, MD, Matías Chacón, MD, Noemí Reguart, MD, PhD, Claudio Martín, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 2, Pp 100456- (2023)
Limited strategies are available at disease progression on osimertinib for patients with EGFR-mutant NSCLC. The emergence of the on-target EGFR C797S mutation has been described as one of the most common mechanisms of resistance. In addition, loss of
Externí odkaz:
https://doaj.org/article/4cf1881df756425180434e27468b9615
Autor:
Dana Narváez, Federico Waisberg, Tomas Soule, Martín Angel, Luisina Bruno, Maria Romina Girotti, Carmen Pupareli, Matías Chacón, Fernando E Petracci
Publikováno v:
ecancermedicalscience. 16
Autor:
Yamil Damián Mahmoud, Martín Angel, Florencia Tsou, Romina Girotti, Romina Luca, Federico Losco, Fernando Petracci, Claudio Martin, Juan Manuel O'Connor, Mariano Leiva, Carmen Pupareli, Matías Chacón, Federico Esteso, Tomas Jose Soule
Publikováno v:
ecancermedicalscience
Background The role of the molecular tumour board (MTB) is to recommend personalised therapy for patients with cancer beyond standard-of-care treatment. A comprehensive molecular analysis of the tumour in a molecular pathology laboratory is important
Autor:
Romina Luca, Alicia I. Bravo, Florencia Tsou, José Mordoh, Claudio Martin, Walter Astorino, Gerardo Rubén Cueto, Pablo Mandó, Estefanía Paula Juliá, Estrella Mariel Levy, Carmen Pupareli, Manglio Rizzo
Publikováno v:
Cancer immunology, immunotherapy : CII. 68(10)
Patients with non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC) have shown benefit from anti-PD-1 therapies. However, not all patients experience tumor shrinkage, durable responses or prolonged survival, demonstrating the need to find
Autor:
Matías Chacón, Sandra Rojo, Adriel Rodríguez Espindola, Enrique Roca, Martin Eleta, Guillermo Mendez, Carmen Pupareli
Publikováno v:
Future Oncology. 11:953-964
ABSTRACT Introduction: Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. 18F-fluorodeoxyglucose PET computed tomography (FDG PET/CT) shows a faster response than computed tomography in nonpretreated patients. Pa
Tumores carcinoides pulmonares tratados quirúrgicamente valor pronóstico de la 7ª estadificación TNM
Autor:
Ana K Patané, Claudia Poleri, Claudio Martín, Carmen Pupareli, Adolfo Rosales, Héctor Rivero, Oscar Rojas, Moisés Rosenberg
Publikováno v:
Medicina (Buenos Aires), Vol 74, Iss 6, Pp 437-442 (2014)
Con el objetivo de evaluar el valor pronóstico de la 7a estadificación TNM se analizaron 43 mujeres (61%) y 28 hombres (39%) con diagnóstico de tumor carcinoide tratados quirúrgicamente desde enero/1975 hasta diciembre/2011. Mediana de edad: 38 a
Autor:
Marcelo Zylberman, Moisés Rosemberg, Daniel Santos, Carmen Pupareli, Adolfo Rosales, Ana K. Patané, Natalio Gastaldello
Publikováno v:
Revista Argentina de Cardiología, Vol 78, Iss 2, Pp 114-117 (2010)
RESUMENIntroducciónEl derrame pericárdico maligno recidiva en hasta el 62% de los pacientes luego de unapericardiocentesis. Debido a ello, se ha intentado completar el tratamiento con la instilaciónintrapericárdica de drogas luego del drenaje de
Autor:
Angela R. Solano, Pasquale Battista, Serena Veschi, Renato Mariani-Costantini, Ernesto J. Podestá, Annalisa Morgano, Gitana Aceto, Carmen Pupareli, Reinaldo Chacón, Antonio Marchetti, Maria Isabel Neuman, Mercedes Lombardi, Sara Malatesta
Publikováno v:
Breast Cancer Research and Treatment. 122:671-683
Juvenile breast cancer is rare and poorly known. We studied a series of five breast cancer patients diagnosed within 25 years of age that included two adolescents, 12- and 15-years-old, and 3 young women, 21-, 21-, and 25-years-old, respectively. All
Autor:
Matías, Chacón, Martín, Eleta, Adriel Rodríguez, Espindola, Enrique, Roca, Guillermo, Méndez, Sandra, Rojo, Carmen, Pupareli
Publikováno v:
Future oncology (London, England). 11(6)
Imatinib is the standard first-line therapy for advanced gastrointestinal stromal tumor. (18)F-fluorodeoxyglucose PET computed tomography (FDG PET/CT) shows a faster response than computed tomography in nonpretreated patients.After disease progressio